1. Market Research
  2. > Media
  3. > Publishing Market Trends
  4. > Loestrin 24 Fe-API Insights, 2016

Loestrin 24 Fe-API Insights, 2016

  • November 2016
  • -
  • Delve Insight
  • -
  • 35 pages



The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

DelveInsight’s, Loestrin 24 Fe -API Insights, 2016 Report provides marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drug. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent, patent exclusivity information and competitive landscape. The research, analysis also presents the global sales forecasts data till 2015.

Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated drug.

Scope

- A review of the Loestrin 24 Fe based on information derived from company and industry-specific sources
- Coverage of the Marketed data of the Loestrin 24 Fe on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
- Coverage of the United States Drug Master File (US DMF), Active Substance Master File/EU DMF and API Manufactures in China & India for drug with location details.
- Patent Expiry Timeline and Exclusivity Details
- Global Forecasted Sales Figure from 2011-2015
- Qualitative and quantitative assessment of market space
Reasons to buy

- Evaluate the marketing status and exclusivity details of Loestrin 24 Fe to exploit opportunities for generic drug development opportunities.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Loestrin 24 Fe.
- API intelligence over Loestrin 24 Fe and gaining primary intelligence over Active Ingredients manufacturers across the globe.
- Uncovering opportunities in the rapidly growing the US market
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Obtain sales forecast for currently marketed drug for 2011-2015

Table Of Contents

Loestrin 24 Fe-API Insights, 2016

Illustrative Table of contents


- Drug Overview
- Global Sales Assessment
- Product Description
- Mechanism of Action
- Pharmacodynamic Properties
- Pharmacokinetic Properties
- Marketed Details for the United States
- Marketed Details for the Europe
- Patent Information
- Patent and Exclusivity Expiry Assessment United States (US)
- Patent Numbers and Expiry Details
- Patent Details
- Global API Manufacturers Assessment
- The United States Drug Master File (US DMF)
- The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
- The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status
- The Active Pharmaceutical Ingredient (API) Manufacturers by Region
- The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
- Generic Players
- Company Profile
- Summary
- Company Financials
- References
- Appendix
- Methodology
- About DelveInsight
- Contact Us
- Disclaimer

List of Tables

- Loestrin 24 Fe, Market, Global Sales (in USD), 2016
- Loestrin 24 Fe, Description
- Loestrin 24 Fe, Marketed Details the United States (US)
- Loestrin 24 Fe, Marketed Details the Europe (EU)
- Loestrin 24 Fe, Patent/Exclusivity Expiry (Year), 2016
- Loestrin 24 Fe, Patent Number Specific Patent Expiry (Year), 2016
- Loestrin 24 Fe, Patent Details
- Loestrin 24 Fe, the United States Drug Master File (US DMF), 2016
- Loestrin 24 Fe, the Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF), 2016
- Loestrin 24 Fe, the API Manufacturers, China, 2016
- Loestrin 24 Fe, the API Manufacturers, India, 2016
- Loestrin 24 Fe, the API Manufacturers by the US DMF Status, 2016
- Loestrin 24 Fe, the API Manufacturers by Region, 2016
- Loestrin 24 Fe, the API Manufacturers by Location/Countries, 2016
- Loestrin 24 Fe, Generic Players, 2016
- Company Overview, 2016
List of Figures

- Loestrin 24 Fe, Market, Global Sales (in million USD), 2016
- Loestrin 24 Fe, Global Sales % Change, 2016
- Loestrin 24 Fe, Patent/Exclusivity Expiry (Year), 2016
- Loestrin 24 Fe, Patent Number Specific Patent Expiry (Year), 2016
- Loestrin 24 Fe, the API Manufacturers by the US DMF Status (%), 2016
- Loestrin 24 Fe, the API Manufacturers by Region, 2016
- Loestrin 24 Fe, the API Manufacturers by Location/Countries, 2016
- Loestrin 24 Fe, Generic Players, 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Malt-based Ingredients: Global Market Intelligence (2011-2020)

Malt-based Ingredients: Global Market Intelligence (2011-2020)

  • $ 4675
  • Industry report
  • November 2016
  • by Sprout Intelligence

REPORT OBJECTIVES The report “Malt-based Ingredients: Global Market Intelligence (2011-2020)” provides market intelligence on the different market segments, based on type, form, grade, application ...

Fermentation Ingredients: Global Market Intelligence (2011-2020)

Fermentation Ingredients: Global Market Intelligence (2011-2020)

  • $ 4675
  • Industry report
  • November 2016
  • by Sprout Intelligence

REPORT OBJECTIVES The report “Fermentation Ingredients: Global Market Intelligence (2011-2020)” provides market intelligence on the different market segments, based on type, application, and geography. ...

Rendered Products: Global Market Intelligence (2011-2020)

Rendered Products: Global Market Intelligence (2011-2020)

  • $ 4675
  • Industry report
  • November 2016
  • by Sprout Intelligence

REPORT OBJECTIVES The report “Rendered Products: Global Market Intelligence (2011-2020)” provides market intelligence on the different market segments, based on type, source, application, and geography. ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.